https://doi.org/10.1016/j.canlet.2019.03.046
Y
Yoshihiro Umezawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
778
Citations
17
h-index
20
i10-index
Yoshihiro Umezawa is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 17, co-authored 85 publications.
ORCID: 0000-0003-1027-1552Papers by this author
worksInhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress
2019 · Cancer Letters · 36 citations
Management of inpatient chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies: an analysis using the Japanese Diagnosis Procedure Combination database
2025 · International Journal of Hematology · 0 citations
https://doi.org/10.1007/s12185-025-04043-8
Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy
2026 · Journal of Neuro-Oncology · 0 citations
https://doi.org/10.1007/s11060-026-05435-4
Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers
2026 · Annals of Hematology · 0 citations
https://doi.org/10.1007/s00277-026-06810-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat